PO.MCB07.01 · 分子与细胞生物学

从肽段筛选到生物学洞见:FOXO4与PBAF复合物

From peptide screens to biological insights, FOXO4 and the PBAF complex

海报缩略图:从肽段筛选到生物学洞见:FOXO4与PBAF复合物
编号 4768 展板 18 时间 4/21 09:00–12:00 区域 Section 24 主讲 Dieu An Nguyen, PhD
分会场 Oncogenic Transcription Factors and Cancer Programs
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Dieu An Hoang Nguyen1, Andrea Cochran2, Shalini Gupta1, E Megan Flynn1

1Genentech, Inc., South San Francisco, CA,2Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA

摘要 Abstract

中文摘要
溴结构域(Bromodomain)在染色质调控因子中普遍存在,尽管它们是潜在令人振奋的癌症治疗靶点,但其中许多的具体功能仍不明确。在一项针对潜在溴结构域结合伙伴的高通量肽段筛选中,转录因子FOXO1/3/4的乙酰化肽段作为显著结合物与多溴蛋白PBRM1(SWI/SNF染色质重塑复合物PBAF的一个亚基)结合而浮现出来。FOXO家族尤其引人关注,因为它们是细胞应激适应的高度保守介导者,并受多种翻译后修饰(PTM)调控。在氧化应激下,FOXO被乙酰化并转位至细胞核,PBRM1即在PBAF内驻留于此。我们试图表征乙酰化FOXO与PBRM1之间的相互作用及其在应激反应中的潜在协作。(1)我们通过等温滴定量热法(ITC)验证了该相互作用,发现乙酰化FOXO肽段与PBRM1溴结构域的结合亲和力可与包含首选组蛋白修饰H3K14ac的肽段相媲美。(2)我们以纯化的、位点特异性乙酰化的FOXO4蛋白作为诱饵,纯化相互作用物进行质谱分析,发现在K189位乙酰化的FOXO4与PBAF组分相互作用。(3)我们运用基因组分析实验ATAC-seq、CUT&RUN-seq和Bru-Seq,剖析FOXO4在内源条件下与氧化应激下的作用,部分研究还在FOXO4 CRISPR敲除细胞中进行。我们识别出FOXO4和PBRM1共定位并在急性应激下峰强度发生变化的峰位。我们还建立了细胞对氧化应激反应的转录谱,并将受影响基因与FOXO4和PBRM1结合的基因进行比较。虽然我们的发现提示FOXO4-PBRM1相互作用可能不是氧化应激反应中转录的关键驱动因素,但这一框架使我们能够系统性地评估该相互作用的其他潜在功能。总之,通过结合生物物理、生物化学、细胞生长实验和功能基因组学实验,我们界定了肿瘤抑制因子PBRM1生物学的一个可能方面,即对FOXO转录因子基因组定位的调控。
查看英文原文 English abstract
Bromodomains are ubiquitous among chromatin regulators, and while they are potentially exciting therapeutic targets for cancer, the specific functions of many of them remain unknown. In a high-throughput peptide screen for potential bromodomain binding partners, acetylated peptides of transcription factors FOXO1/3/4 emerged as significant binders to the polybromo protein PBRM1, a subunit of the SWI/SNF chromatin remodeler PBAF. FOXOs are of particular interest because they are well-conserved mediators of stress adaptation in cells and are regulated by several PTMs. Under oxidative stress, FOXOs are acetylated and translocate to the nucleus, where PBRM1, within PBAF, resides. We sought to characterize the interaction between acetylated FOXOs and PBRM1 and their potential cooperation in stress responses. (1) We validated the interaction by Isothermal titration calorimetry (ITC) and found acetylated FOXO peptides bind to PBRM1 bromodomains with affinities comparable to peptides including the preferred histone modification, H3K14ac. (2) Using purified, site-specifically acetylated FOXO4 proteins as bait, we purified interactors for mass spec analysis, finding that FOXO4 acetylated at K189 interacts with PBAF components. (3) We employed genomic profiling assays ATAC-seq, CUT&RUN-seq, and Bru-Seq to dissect the role of FOXO4 under endogenous conditions versus oxidative stress, with select studies also performed in FOXO4 CRISPR knockout cells. We identified peaks where FOXO4 and PBRM1 co-localize and exhibit changes in peak intensity under acute stress. We also established a transcriptional profile of cellular response to oxidative stress and compared affected genes to the genes bound by FOXO4 and PBRM1. While our findings suggest that the FOXO4-PBRM1 interaction may not be the key driver of transcription in the oxidative stress response, this framework allows us to systematically assess other potential functions of the interaction. Together, by combining biophysical, biochemical, cell growth assays, and functional genomics assays, we have defined a likely aspect of the biology of the tumor suppressor PBRM1, namely regulation of FOXO transcription factor genomic localization.
利益披露 Disclosure
D. H. Nguyen, Genentech Inc., Roche Employment. Bristol Myers Squibb Stock. GSK Pharmaceuticals Stock. A. Cochran, Genentech Inc., Roche Employment. Abbott Stock. Abbvie Stock. Amgen Stock. Merck Stock. Novartis Stock. Alcon Stock. Sandoz Stock. Lilly Stock. Novo Nordisk Stock. Organon Stock. S. Gupta, Genentech Inc., Roche Employment. Abbvie Stock. Alnylam Stock. Lilly Stock. Merck Stock. Novo Nordisk Stock. E. Flynn, Genentech Inc., Roche Employment, Stock.

← 返回 AACR 2026 检索